All In Biotech

Drug Trial Radar · NCT00056524

Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

An Open-Label Multicenter Study to Assess the Safety of AVP-923 in the Treatment of Patients With Pseudobulbar Affect.

Last checked: Nov 19, 2026Latest source record: Jul 14, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

600

Planned (sponsor's estimate)

Start

Feb 2003

Primary completion

Jun 2007

Study completion Jun 2007

Sponsor

Lead sponsor
Avanir PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Mar 18, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the long-term safety of AVP-923 in the treatment of Involuntary Emotional Expression Disorder (IEED) also known as Pseudobulbar Affect (episodes of uncontrolled crying and/or laughter).

Conditions

  • Alzheimer's Disease
  • Stroke
  • Parkinson's Disease
  • Traumatic Brain Injury

Interventions

  • AVP-923Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. emotional control

Locations

39 sites in 1 country. Site status is shown where the registry gives one.

  • Barrow Neurological Institute

    Phoenix, Arizona

  • Center for Neurologic Study

    La Jolla, California

  • UCLA School of Medicine

    Los Angeles, California

  • UCSF

    San Francisco, California

  • Research Center for Clinical Studies, Inc.

    Darien, Connecticut

  • George Washington University Medical Faculty Assoc.

    Washington D.C., District of Columbia

  • Neurological Associates

    Fort Lauderdale, Florida

  • University of Miami Dept. of Neurology

    Miami, Florida

  • Miami Jewish Home & Hospital for the Aged

    Miami, Florida

  • Allied Clinical Trials

    Miami, Florida

  • Renstar Medical Research

    Plantation, Florida

  • Suncoast Neuroscience Associates Inc.

    St. Petersburg, Florida

  • Site not named

    Tampa, Florida

  • Neurology & Headache Specialist of Atlanta, L.L.C.

    Decatur, Georgia

  • Consultants in Neurology LTD

    Northbrook, Illinois

  • Advanced Neurology Specialists

    Great Falls, Montana

  • Neurological Associates, P.C.

    Lincoln, Nebraska

  • Upstate Clinical Research

    Albany, New York

  • DENT Neurologic Group L.L.P.

    Amherst, New York

  • Hospital for Joint Diseases MS Care Center

    New York, New York

  • SUNY Upstate Medical University

    Syracuse, New York

  • Carolinas Medical Center

    Charlotte, North Carolina

  • Raleigh Neurology Associates, PA

    Raleigh, North Carolina

  • NeuroCare Center, Inc.

    Canton, Ohio

  • MetroHealth Medical Center

    Cleveland, Ohio

  • University Memory and Aging Center

    Cleveland, Ohio

  • The Cleveland Clinic Foundation

    Cleveland, Ohio

  • Clinical Pharmaceutical Trials, Inc.

    Tulsa, Oklahoma

  • Lehigh Valley Neurosciences and Pain Research Center

    Allentown, Pennsylvania

  • Westmoreland Neurology

    Greensburg, Pennsylvania

  • Site not named

    Jenkintown, Pennsylvania

  • MCP-Hahnemann University

    Philadelphia, Pennsylvania

  • Penn Neurological Institute

    Philadelphia, Pennsylvania

  • Neurological Associates of Delaware Valley

    Upland, Pennsylvania

  • Claghorn-Lesem Research Clinic

    Bellaire, Texas

  • Methodist Neurological Institute

    Houston, Texas

  • Fletcher Allen Health Care

    Burlington, Vermont

  • Neurology and Neurosurgery Associates of Tacoma

    Tacoma, Washington

  • University of Wisconsin

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.